VERSATECH INC
10QSB, 2000-11-14
MISCELLANEOUS RETAIL
Previous: MIRAVANT MEDICAL TECHNOLOGIES, 10-Q, EX-27.1, 2000-11-14
Next: VERSATECH INC, 10QSB, EX-27, 2000-11-14



                U. S. Securities and Exchange Commission

                        Washington, D.C., 20549
                              Form 10-QSB

(Mark One)

[ X ]   QUARTERLY REPORT PURSUANT SECTION 13 OR 15(d) OF THE
        SECURITIES EXCHANGE ACT OF 1934

        For the quarterly period ended September 30, 2000

[   ]   TRANSITION REPORT PURSUANT SECTION 13 OR 15(d) OF THE
        SECURITIES EXCHANGE ACT OF 1934

        For the transition period from ______ to ________

               Commission file number  000-22729

-----------------------------------------------------------------

                          VERSATECH, INC.
(Exact name of small business issuer as specified in its charter)

-----------------------------------------------------------------

                             Nevada
 (State or other jurisdiction of incorporation or organization)


                           88-0330263
                 (IRS Employer Identification No.)

-----------------------------------------------------------------

               300 Keystone Street, Hawley, PA 18428
             (Address of principal executive offices)

-----------------------------------------------------------------

                         (570) 226-8515
                  (Issuer's telephone number)

-----------------------------------------------------------------

Check whether the issuer (1) filed all reports required to be
filed by Section 13 or 15(d) of the Exchange Act during the past
12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.

                       Yes [X]     No [ ]

APPLICABLE ONLY TO CORPORATE ISSUERS

State the number of shares outstanding of each of the issuer's
classes of common equity, as of the latest practicable date: As
of October 31, 2000 the issuer had 13,854,228 shares of common
stock outstanding.

Transitional Small Business Disclosure Format (Check one);
                       Yes  [ ]    No  [X]

<PAGE>
                    PART I- FINANCIAL INFORMATION

Item 1.   Financial Statements.

The unaudited consolidated financial statements presented herein
have been prepared by the Company in accordance with the
instructions to Form 10-QSB and do not include all of the
information and note disclosures required by generally accepted
accounting principles. These consolidated financial statements
should be read in conjunction with the audited financial
statements and notes thereto for the period ended December 31,
1999 included in the Company's Form 10-KSB for the period ended
December 31, 1999. The accompanying financial statements have not
been examined by independent accountants in accordance with
generally accepted auditing standards, but in the opinion of
management such financial statements include all adjustments
necessary to present fairly the Company's financial position and
results of operations. The results of operations for the nine
months ended September 30, 2000 may not be indicative of the
results that may be expected for the year ending December 31,
2000.

<PAGE>
                        Versatech, Inc.

            (Formerly D H Marketing & Consulting, Inc.)

                        And Subsidiaries

               Consolidated Financial Statements

                       September 30, 2000


<PAGE>

                          Versatech, Inc.
                    Consolidated Balance Sheets

                               ASSETS
                               ------

                                     September 30   December 31
                                         2000           1999
                                    -------------  -------------
CURRENT ASSETS                        (unaudited)

   Cash and Cash Equivalents        $      10,499  $      24,609
   Accounts receivable, Net of
     Allowance $54,749 and $54,749         24,556         25,229
   Other Receivables                        3,869          3,886
   Inventory                              130,873        139,296
                                    -------------  -------------

     Total Current Assets                 169,797        193,020
                                    -------------  -------------

INVESTMENTS
   Investments - Other                     46,903         46,903
                                    -------------  -------------

      Total Investments                    46,903         46,903
                                    -------------  -------------

PROPERTY & EQUIPMENT
   Office Furniture and Fixtures           20,184         20,184
   Equipment                              188,976        188,976
   Leasehold Improvements                  17,668         17,668
   Building                               200,000        200,000
   Land                                   197,996        197,996
   Accumulated Depreciation              (187,228)      (175,628)
                                    -------------  -------------

     Net Property & Equipment             437,596        449,196
                                    -------------  -------------

OTHER ASSETS
    Software Development                   16,875         22,500
    Deposits and Other Assets               6,450          6,450
    Arts & Collectibles                 1,422,396      1,422,396
                                    -------------  -------------

      Net Other Assets                  1,445,721      1,451,346
                                    -------------  -------------

     TOTAL ASSETS                   $   2,100,017  $   2,140,465
                                    =============  =============


 The accompanying notes are an integral part of these financial statements.
                                         -2-

<PAGE>

                           Versatech, Inc.
              Consolidated Balance Sheets continued


               LIABILITIES AND STOCKHOLDERS' EQUITY
               ------------------------------------

                                     September 30   December 31
                                         2000           1999
                                    -------------  -------------
CURRENT LIABILITIES                   (unaudited)

   Accounts Payable                 $     116,564  $      89,384
   Sales Tax Payable                        1,051          1,211
   Accrued Wages                            1,561          2,925
   Accrued Expenses                           497            235
   Deferred Tax Liability                   1,587          1,587
   Current Obligations Under
      Capital Lease                         3,050          3,880
  Current portion of Notes
      Payable & Mortgage Payable          144,323         93,674
                                    -------------  -------------

         Total Current Liabilities        268,633        192,896
                                    -------------  -------------

LONG-TERM DEBT

   Mortgage Payable                       288,070        293,332
   Notes Payable - Related Party          131,679         81,030
   Obligation Under Capital Lease           3,502          5,914
     Less: Current Portion               (147,373)       (97,554)
                                    -------------  -------------

     Total Long-Term Debt                 275,878        282,722
                                    -------------  -------------

         Total Liabilities                544,511        475,618

STOCKHOLDERS' EQUITY

   Common stock, $.0003 Par Value,
     Authorized 75,000,000
     Shares; issued and outstanding
     11,850,964 and 11,850,964
     shares, respectively                   3,555          3,555
   Additional Paid-In Capital           9,527,682     10,255,182
   Treasury Stock                         (36,016)      (786,016)
   Stock subscription receivable         (240,000)      (240,000)
   Retained earnings                   (7,699,715)    (7,567,874)
                                    -------------  -------------

     Total Stockholders' Equity         1,555,506      1,664,847
                                    -------------  -------------

TOTAL LIABILITIES AND STOCKHOLDERS'
EQUITY                              $   2,100,017  $   2,140,465
                                    =============  =============

 The accompanying notes are an integral part of these financial statements.
                                       -3-

<PAGE>

                          Versatech, Inc.
              Consolidated Statements of Operations

<TABLE>
<CAPTION>

                                 For the three    For the three    For the nine    For the nine
                                 months ended     months ended     months ended    months ended
                                 September 30     September 30     September 30    September 30
                                     2000             1999             2000             1999
                                 --------------   -------------    -------------   --------------
<S>                              <C>              <C>              <C>             <C>
SALES                            $        9,725   $     320,723    $      59,767   $      961,897

COST OF GOODS SOLD                        3,335          89,683           14,166          535,085
                                 --------------   -------------    -------------   --------------

GROSS PROFIT                              6,390         231,040           45,601          426,812
                                 --------------   -------------    -------------   --------------

OPERATING EXPENSES
   General And Administrative
      Expenses                           48,859         137,637          165,083          843,109
                                 --------------   -------------    -------------   --------------

TOTAL OPERATING EXPENSES                 48,859         137,637          165,083          843,109
                                 --------------   -------------    -------------   --------------

OPERATING INCOME (LOSS)                 (42,469)         93,403         (119,482)
(416,297)
                                 --------------   -------------    -------------   --------------

OTHER INCOME AND (EXPENSES)
   Interest Expense                        (124)           (395)         (12,862)
(782)
   Other Income                            -                352             -               5,417
   Gain on Sale of Investments             -               -                -                 320
                                 --------------   -------------    -------------   --------------

     Total Other Income and
         (Expenses)                        (124)            (43)         (12,862)           4,955
                                 --------------   -------------    -------------   --------------

NET INCOME (LOSS)                $      (42,593)  $      93,360    $    (132,344)  $
(411,342)
                                 ==============   =============    =============   ==============

NET INCOME (LOSS) PER SHARE      $        (.003)  $        .011    $       (.011)  $
(.049)
                                 ==============   =============    =============   ==============

WEIGHTED AVERAGE NUMBER
   OF COMMON SHARES                  11,850,964       8,419,964       11,850,964        8,419,964
                                 ==============   =============    =============   ==============


</TABLE>
  The accompanying notes are an integral part of these financial statements.
                                     -4-

<PAGE>

                          Versatech, Inc.
               Consolidated Statements of Cash Flows

                                              For the nine     For the nine
                                              months ended     months ended
                                              September 30     September 30
                                                  2000             1999
                                            ---------------   ---------------

Cash Flows From Operating Activities

Net income (loss)                           $      (132,344)  $      (411,342)
Adjustments to Reconcile Net Income (Loss)
  to Net Cash Used in Operating Activities:
   Depreciation                                      11,600            42,037
   Amortization                                       5,625             4,108
 Change in Assets and Liabilities
  (Increase) Decrease in:
   Accounts Receivable                                  673          (301,745)
   Other Receivables                                     17               100
   Inventory                                          8,423            65,053

  Increase/(decrease) in:
   Accounts Payable                                  27,180           (12,677)
   Accrued Expenses                                  (1,262)         (123,520)
                                            ---------------   ---------------

     Net Cash Provided (Used) by
         Operating Activities                       (80,088)         (737,986)
                                            ---------------   ---------------

Cash Flows from Investing Activities
  Purchase of Property and Equipment                   -               (6,415)
                                            ---------------   ---------------

     Net Cash Provided (Used) by
         Investing Activities                          -               (6,415)
                                            ---------------   ---------------

Cash Flows from Financing Activities

  Proceeds from sale of treasury stock               22,500              -
  Proceeds from debt financing                       50,649            29,900
  Principal Payments on capital lease
      obligations                                    (1,909)           (1,592)
  Principal Payments on mortgage payable             (5,262)             -
  Proceeds from stock subscriptions                    -              436,072
                                            ---------------   ---------------

     Net Cash Provided (Used) by
          Financing Activities                       65,978           464,180
                                            ---------------   ---------------

Net Increase (Decrease) in Cash and
    Cash Equivalents (Forwarded)                    (14,110)         (280,221)
                                            ---------------   ---------------

Cash and Cash Equivalents
  Beginning                                          24,609           308,838
                                            ---------------   ---------------

  Ending                                    $        10,499   $        28,617
                                            ===============   ===============

Supplemental Disclosures of Cash Flow
Information:
  Cash payments for interest                $        12,862   $           782
                                            ===============   ===============
  Cash payments for income taxes            $          -      $          -
                                            ===============   ===============

Supplemental Schedule of Noncash
Investing and Financing Activities
  Purchase of Inventory through Issuance
       of Company Stock                     $          -      $          -
                                            ===============   ===============


  The accompanying notes are an integral part of these financial statements.
                                  -5-

<PAGE>
                          Versatech, Inc.
               September 30, 2000 and December 31, 1999

NOTES TO FINANCIAL STATEMENTS

Versatech, Inc. (the "Company") has elected to omit substantially
all footnotes to the financial statements for the nine months
ended September 30, 2000, since there have been no material
changes (other than indicated in other footnotes) to the
information previously reported by the Company in their Annual
Report filed on Form 10-KSB for the Fiscal year ended December
31, 1999.

UNAUDITED INFORMATION

The information furnished herein was taken from the books and
records of the Company without audit. However, such information
reflects all adjustments which are, in the opinion of management,
necessary to properly reflect the results of the period
presented.  The information presented is not necessarily
indicative of the results from operations expected for the full
fiscal year.

















                              -6-

<PAGE>

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS AND PLAN OF
OPERATION.

Management's Discussion and Analysis

This Form 10-QSB includes, without limitation, certain statements
containing the words "believes", "anticipates", "estimates",
"expects" and words of a similar nature which constitute
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. This Act provides a
"safe harbor" for forward-looking statements to encourage
companies to provide prospective information about themselves so
long as they identify these statements as forward looking and
provide meaningful, cautionary statements identifying important
factors that could cause actual results to differ from the
projected results. All statements other than statements of
historical fact made in this Form 10-QSB are forward-looking. In
particular, the statements herein regarding the new marketing
plan's impact on sales for the upcoming quarters and beyond, the
impact that management's familiarity with the marketing plan will
have on sales figures in the future, future plans regarding the
purchase or sale of significant equipment and future plans regarding
the increase or decrease in the number of employees are forward-
looking statements. Forward-looking statements reflect management's
current expectations and are inherently uncertain. The Company's
actual results may differ significantly from management's
expectations.

Overview
--------

The Company is a 100% equity owner of Universal Network of
America, Inc.("UNIA"), a direct sales organization distributing
various health building products such as aloe based skin care
products and UNItropin hGH Formula Plus, an all natural dietary
supplemental tablet. These products are distributed both in the
wholesale and retail markets via sales representatives and the
increasing presence on the internet.

In April, 1999, the Company introduced LongerLiving.com as a new
domain. The intent of the new website is to become the leading
provider of quality content covering anti-aging advances and
health on the Internet. The website was expanded in September of
1999 in order to enhance the range of health issues and features.
This led to the eventual incorporation of LongerLiving.com, Inc.
in December of 1999 as a subsidiary of the Company. In the coming
months, it is anticipated that revenues will be generated by
sponsorships, banner advertising and co-branding.

In an effort to boost sales and stockholder confidence, it was
announced at the shareholder's meeting on March 15, 2000 that the
Company was officially changing its name from D. H. Marketing &
Consulting, Inc. to Versatech, Inc.

In an announcement made on March 28, 2000, Universal Network,
Inc. has reached an agreement with Commission Junction to launch
an affiliate program for UNItropin. Commission Junction is a web
based, e-commerce network that matches online merchant's products
and services to online content providers and provides management
services from these resulting relationships.

Versatech, Inc. has almost completed a management consulting
agreement with Rapid Release, LLC and Rapid's affiliate, Jacob
International, Inc. It is expected that both companies will
assist the Company in the development and implementation of
distribution and marketing programs for their anti-aging
products. They will also provide guidance for the Company as it
develops its short and long term business plans and objectives.
Rapid Release will also work with the Company to develop investor
awareness and to make the investment community aware of new
developments. With the assistance of these 2 entities, the
Company will pursue strategies to increase capitalization in
order to expand business activities and to complete financing
that will enable the Company to broaden the distribution of
UNItropin and further the development of LongerLiving.

Selected Financial Data
-----------------------

                     for 3 mos     for 3 mos    for 9 mos    for 9 mos
                       ending        ending       ending       ending
                       9/30/00       9/30/99      9/30/00     9/30/99

Sales              $      9,725   $   320,723  $    59,767  $ 961,897

Cost of Goods Sold $      3,335        89,683       14,166    535,085

Net Income         $    (42,593)       93,360     (132,344)  (411,342)

Net Income/Share   $      (.003)         .011        (.010)     (.049)

Weighted Average     13,264,964     8,419,964   13,264,964  8,419,964
# Common Shares

Liquidity
---------

The Company posted a net loss of $42,593 for the third quarter
of 2000. The amount of net loss for the Company has continued to
reduce in size from the prior two quarters of 2000. The Company
has reduced operating expenses by 45% as compared to the third
quarter of 1999.

The Company has recorded Total Current Assets of $169,797 as of
September 30, 2000. This breakdown includes $10,499 in cash or
cash equivalents, $28,425 in accounts receivable and the balance
was held in inventory at $130,873. Total current assets reflect a
97% reduction as compared to the third quarter of 1999 where the
value at that time was $5,532,434.  The Company numbers for the
year 2000 reflect the large inventory valuation adjustment that
was done at year end 1999.

Capital Resources
-----------------

As of September 30, 2000, the Total Stockholder Equity was
$1,555,506 as compared with $5,694,753 for the same period in
1999. This represents a 73% reduction in stockholders equity.

Cash Expenditures
-----------------

Total general and administrative expenses decreased from $137,637
on September 30, 1999 to $48,859 on September 30, 2000. The
Company has engaged a concerted effort to reduce operating
expenses to a bare minimum in order to rebuild its position in
the marketplace. The Company has been able to continue the trend
of reducing expenses by 20% or more in each quarter of 2000.

Long Term Debt/Current Liabilities
----------------------------------

The Company has outstanding liability in the area of Accounts
Payable which has $116,564. The Company has a minor capital lease
for office equipment in the amount of $3,502. The major
outstanding long term liability continues to be the mortgage on
the building located in Sarasota, Florida. In January, 1999, the
Company purchased this property and the present value on the
outstanding mortgage is $288,070.

Revenue
-------

Total revenue, less sales discounts has decreased from $320,723
on September 30, 1999 to $9,725 on September 30, 2000. The
Company is now focusing its direction towards the internet and
the development of its presence in that arena. Management
anticipates that the internet is the key to the future success of
the Company. The initial product introduced in 1999 was a dietary
supplement called UNItropin. The Company is in the process of
developing a new packaging for the product which will give it a
much longer shelf life. It is anticipated that this new packaging
will be introduced during the 4th quarter of 2000. The Company is
also researching some variations to UNItropin which could be
introduced in early 2001.

Plan of Operation
-----------------

Versatech, Inc. (formerly D.H. Marketing & Consulting, Inc.) was
incorporated in Nevada in 1994 and has divested itself of all
operations to turn its focus towards its two subsidiaries,
Universal Network, Inc. and LongerLiving.com, Inc.

Universal Network, Inc.
-----------------------

Universal Network, Inc. was acquired by the Company in 1997.
Universal Network, Inc. originally focused on wealth building
products with intrinsic value such as gold coins, jewelry
lithographs and other collectible items. In 1998, the focus of
Universal turned towards the health sector when it engaged in an
aloe vera based product line of skin care items. The initial
success of this product enticed Universal to expand in the health
sector and in late 1998, it introduced UNItropin hGH Formula
Plus, a human growth hormone all natural dietary supplemental
tablet. The product in the existing marketing plan was not an
overwhelming success so Universal Network has been working over
the past several months to overhaul the plan. Universal Network
is about to unveil an aggressive, powerful marketing plan that is
Internet driven. In conjunction with Commission Junction, a web
based e-commerce organization located in California, the Company
will be significantly enhancing its presence on the website. With
the additional assistance of the new consulting firms on board,
the Company will attain the financing and guidance needed to
return the Company to the successful level of business it
achieved a few years ago.

LongerLiving.com, Inc.
----------------------

LongerLiving.com, Inc. was established in 1999. This subsidiary
will be the information provider for the health sector for the
future. This site will provide the viewer a wide range of health
related topics and features on the most up to the minute
information in the health sector. It is anticipated that
significant revenues will be generated from this subsidiary
through sponsorships, the co-branding of products and especially
from banner advertising.


                  PART II- OTHER INFORMATION

Items 3, 4 and 5 are not applicable and have been omitted.

ITEM 1. LEGAL PROCEEDINGS

The United States Securities and Exchange Commission is
conducting a formal investigation of the Company, with which the
Company's management is cooperating. The outcome of such
investigation is not known at this time. The Company is not a
party to any material pending legal proceedings and, to the
best of its knowledge, no such action by or against the Company
has been threatened.

ITEM 2.  CHANGES IN SECURITIES

During the three months ended September 30, 2000 the Company
issued 200,000 shares of restricted common stock to one individual
for services rendered, which were valued at $100,000 or $.50 per
share. These shares were issued pursuant to an exemption from
registration under Section 4(2) of the Securities Act of 1933, as
amended.

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K

Exhibits and Reports on Form 8-K (including related comments
thereto) filed as part of this report are listed below:

(a) Exhibits. The following exhibits are filed with this report.

Exhibit No.      Description
-----------      --------------------------------------------

27.0             Financial Data Schedule


(b) REPORTS ON FORM 8-K.

The Company did not file any reports on Form 8-K during the
quarter ended September 30, 2000.

<PAGE>

                            SIGNATURES

In Accordance to the requirements of the Securities Exchange Act
of 1934, the registrant caused this report to be signed on its
behalf by the undersigned, thereunto duly authorized.

                             Versatech, Inc.
                             A Nevada Corporation

November 14, 2000            By: /s/MICHAEL J. DAILY
Date                         Michael J. Daily
                             President, Chief Executive Officer,
                             Secretary and duly authorized
                             officer


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission